Subhadra P Narayanan
Overview
Explore the profile of Subhadra P Narayanan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
133
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sabbineni H, Verma A, Artham S, Anderson D, Amaka O, Liu F, et al.
Biochem Pharmacol
. 2019 Apr;
164:205-215.
PMID: 30991049
Endothelial to mesenchymal transition (EndMT), where endothelial cells acquire mesenchymal characteristics has been implicated in several cardiopulmonary, vascular and fibrotic diseases. The most commonly studied molecular mechanisms involved in EndMT...
2.
Yokota H, Narayanan S, Zhang W, Liu H, Rojas M, Xu Z, et al.
Invest Ophthalmol Vis Sci
. 2011 Sep;
52(11):8123-31.
PMID: 21917939
Purpose: The aim of this study was to determine whether NOX2, one of the homologs of NADPH oxidase, plays a role in neuronal cell death during retinal ischemia. Methods: Ischemia...
3.
Narayanan S, Suwanpradid J, Saul A, Xu Z, Still A, Caldwell R, et al.
PLoS One
. 2011 Aug;
6(7):e22460.
PMID: 21811615
Background: Retinopathy of prematurity (ROP) is a major cause of vision impairment in low birth weight infants. While previous work has focused on defining the mechanisms of vascular injury leading...
4.
Zhang W, Yokota H, Xu Z, Narayanan S, Yancey L, Yoshida A, et al.
Invest Ophthalmol Vis Sci
. 2011 Jun;
52(9):6384-95.
PMID: 21705685
Purpose: To investigate the therapeutic use and mechanisms of action of normobaric hyperoxia to promote revascularization and to prevent neovascularization in a mouse model of oxygen-induced ischemic retinopathy. Methods: Hyperoxia...